These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26189768)
21. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438 [TBL] [Abstract][Full Text] [Related]
22. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813 [TBL] [Abstract][Full Text] [Related]
23. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. Omer B; Kadan-Lottick NS; Roberts KB; Wang R; Demsky C; Kupfer GM; Cooper D; Seropian S; Ma X Br J Haematol; 2012 Sep; 158(5):615-25. PubMed ID: 22775513 [TBL] [Abstract][Full Text] [Related]
24. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study. Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326 [TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group. Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453 [TBL] [Abstract][Full Text] [Related]
26. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. Green DM; Hyland A; Barcos MP; Reynolds JA; Lee RJ; Hall BC; Zevon MA J Clin Oncol; 2000 Apr; 18(7):1492-9. PubMed ID: 10735897 [TBL] [Abstract][Full Text] [Related]
27. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study. Pedersen SB; Nielsen JC; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT Europace; 2015 Jun; 17(6):902-8. PubMed ID: 25840286 [TBL] [Abstract][Full Text] [Related]
29. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort. Trama A; Tittarelli A; Barigelletti G; Botta L; Gatta G; Tagliabue G; Contiero P; Guzzinati S; Andreano A; Manneschi G; Falcini F; Castaing M; Filiberti RA; Gasparotti C; Cirilli C; Mazzucco W; Mangone L; Iacovacci S; Vitale MF; Stracci F; Piffer S; Tumino R; Carone S; Sampietro G; Melcarne A; Ballotari P; Boschetti L; Pisani S; Cavalieri D'Oro L; Cuccaro F; D'Argenzio A; D'Orsi G; Fanetti AC; Ardizzone A; Candela G; Savoia F; Pascucci C; Castelli M; Storchi C; Bernasconi A Cancer; 2022 Jan; 128(2):364-372. PubMed ID: 34582036 [TBL] [Abstract][Full Text] [Related]
30. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074 [TBL] [Abstract][Full Text] [Related]
31. Second malignant neoplasms in childhood malignant brain tumour: a long-term population-based study. Cai Y; Cao L; Bao X; Xie L J Paediatr Child Health; 2012 Nov; 48(11):990-6. PubMed ID: 23039967 [TBL] [Abstract][Full Text] [Related]
32. Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia. Westerveld ASR; Roesthuis P; van der Pal HJH; Bresters D; Bierings M; Loonen J; de Vries ACH; Louwerens M; Koopman MMW; van den Heuvel-Eibrink MM; van der Heiden-van der Loo M; Hoogerbrugge P; Janssens GO; de Krijger RR; Ronckers CM; Pieters R; Kremer LCM; Teepen JC Blood Cancer J; 2024 Aug; 14(1):150. PubMed ID: 39198413 [TBL] [Abstract][Full Text] [Related]
33. Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency. Kim SH; Shin KH; Seok SO; Cho YJ; Noh JK; Suh JS; Yang WI Ann Surg Oncol; 2015 Mar; 22(3):859-65. PubMed ID: 25192682 [TBL] [Abstract][Full Text] [Related]
34. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT). Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040 [TBL] [Abstract][Full Text] [Related]